Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
The New England Journal of Medicine
|
February 23, 2017
Pediatric Drug Formulations - Unintended Consequences of Legislation
Luke A Probst, Thomas R Welch
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
November 3, 2012
Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs
Manika Suryadevara, Kelly E Steidl, Luke A Probst, et al.
The Annals of Pharmacotherapy
|
November 22, 2013
Evaluation of dabigatran utilization and risk among hospitalized patients
Eric Sidman, Luke A Probst, William Darko, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Andexanet Alfa: Preferred Treatment or Therapeutic Option?
Curtis A Blow, Luke A Probst, Christopher D Miller, et al.
Hospital Pharmacy
|
March 28, 2018
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Anne Krasniak, William Darko, Christopher D Miller, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 5, 2010
Rhabdomyolysis associated with phentermine
Kelly E Steidl, William Darko, Luke A Probst, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 5, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
The Annals of Pharmacotherapy
|
June 26, 2020
Recurrent Renal Dysfunction Secondary to Probable Piperacillin-Tazobactam-Induced Acute Interstitial Nephritis
Katie A Parsels, Robert W Seabury, William Darko, et al.
Hospital Pharmacy
|
January 28, 2020
Evaluation of a Long-Acting Opioid Restriction Policy: Does Restriction Reduce the Need for Naloxone Reversal?
Jenna L Fancher, Robert W Seabury, William Darko, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
The New England Journal of Medicine
|
February 23, 2017
Pediatric Drug Formulations - Unintended Consequences of Legislation
Luke A Probst, Thomas R Welch
The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG
|
November 3, 2012
Inappropriate vancomycin therapeutic drug monitoring in hospitalized pediatric patients increases pediatric trauma and hospital costs
Manika Suryadevara, Kelly E Steidl, Luke A Probst, et al.
The Annals of Pharmacotherapy
|
November 22, 2013
Evaluation of dabigatran utilization and risk among hospitalized patients
Eric Sidman, Luke A Probst, William Darko, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Andexanet Alfa: Preferred Treatment or Therapeutic Option?
Curtis A Blow, Luke A Probst, Christopher D Miller, et al.
Hospital Pharmacy
|
March 28, 2018
Changes in Pharmacy Residency Training Design Between 2012 and 2017: A Perspective of Academic Medical Centers
Anne Krasniak, William Darko, Christopher D Miller, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|
November 5, 2010
Rhabdomyolysis associated with phentermine
Kelly E Steidl, William Darko, Luke A Probst, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
September 6, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
P & T : a Peer-Reviewed Journal for Formulary Management
|
June 5, 2019
Evaluation of Warfarin Patients with Low Time in Therapeutic Range (TTR) for Transition to Non-Vitamin-K Oral Anticoagulant (NOAC) Therapy
Lindsey M Fovel, Christopher D Miller, Robert W Seabury, et al.
The Annals of Pharmacotherapy
|
June 26, 2020
Recurrent Renal Dysfunction Secondary to Probable Piperacillin-Tazobactam-Induced Acute Interstitial Nephritis
Katie A Parsels, Robert W Seabury, William Darko, et al.
Hospital Pharmacy
|
January 28, 2020
Evaluation of a Long-Acting Opioid Restriction Policy: Does Restriction Reduce the Need for Naloxone Reversal?
Jenna L Fancher, Robert W Seabury, William Darko, et al.
Page
of 3